Scoping Review of Chemical Adherence Testing for Hypertension Management

A 2026 scoping review by Louise Rabbitt, summarizing 48 studies on chemical adherence testing in hypertension management. The review, published under CC-BY-4.0, analyzes studies from diverse clinical settings identified through systematic searches of Ovid Medline, EMBASE, and PsycInfo.

Use Cases

• Analyze the variability in definitions and frameworks for adherence testing based on the review's findings.
• Identify gaps in clinical trial evidence for chemical adherence testing based on the reported paucity of RCTs.
• Survey the diverse clinical settings and observational study designs used in adherence research as described in the results.

Strengths

• Systematically reviews 48 identified studies from a pool of 618, providing a focused analysis.
• Explicitly documents the search methodology using three major databases (Ovid Medline, EMBASE, PsycInfo) and manual reference checking.
• Published under a permissive CC-BY-4.0 license, facilitating reuse and distribution.

Limitations

• The dataset is a single 193.9 KB PDF document; its scope is limited to the review's text and does not contain the underlying study data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, authored by Louise Rabbitt.

Collection Method

Systematic scoping review conducted using Covidence software for screening and data extraction.

Time Range

Review published in 2026; included studies' publication dates are not specified.

Freshness

Last updated 2026-04-10 05:09:14.

Geography

Studies cover diverse clinical settings, but specific geographic coverage is not detailed.